83 related articles for article (PubMed ID: 36615606)
1. Erythrocyte membrane-camouflaged mesoporous silica composite nanoparticles for loading and controlled release of the hepatoprotective agent silibinin: A-synthesis and physicochemical characterization.
Tayebi Khorrami V; Raee MJ; Abolmaali SS; Abedanzadeh M; Shafiee M; Tamaddon AM
J Pharm Pharmacol; 2024 May; ():. PubMed ID: 38762907
[TBL] [Abstract][Full Text] [Related]
2. Different Targeting Ligands-Mediated Drug Delivery Systems for Tumor Therapy.
Yan S; Na J; Liu X; Wu P
Pharmaceutics; 2024 Feb; 16(2):. PubMed ID: 38399302
[TBL] [Abstract][Full Text] [Related]
3. The utilization of nanotechnology in the female reproductive system and related disorders.
Luo X; Jia K; Xing J; Yi J
Heliyon; 2024 Feb; 10(3):e25477. PubMed ID: 38333849
[TBL] [Abstract][Full Text] [Related]
4. Use of S2.2/DOX Magnetic Nanoliposomes in MR Molecule Imaging and Targeted Thermochemotherapy for Breast Cancer In Vitro.
Zhu Y; Yang D; Guo T; Lin M
Technol Cancer Res Treat; 2023; 22():15330338231194498. PubMed ID: 37563954
[TBL] [Abstract][Full Text] [Related]
5. Indole Antitumor Agents in Nanotechnology Formulations: An Overview.
Russo E; Grondona C; Brullo C; Spallarossa A; Villa C; Tasso B
Pharmaceutics; 2023 Jun; 15(7):. PubMed ID: 37514002
[TBL] [Abstract][Full Text] [Related]
6. Aptamers Versus Vascular Endothelial Growth Factor (VEGF): A New Battle against Ovarian Cancer.
Mishra Y; Chattaraj A; Mishra V; Ranjan A; Tambuwala MM
Pharmaceuticals (Basel); 2023 Jun; 16(6):. PubMed ID: 37375796
[TBL] [Abstract][Full Text] [Related]
7. Rod-shaped mesoporous silica nanoparticles for nanomedicine: recent progress and perspectives.
Cong VT; Gaus K; Tilley RD; Gooding JJ
Expert Opin Drug Deliv; 2018 Sep; 15(9):881-892. PubMed ID: 30173560
[TBL] [Abstract][Full Text] [Related]
8. Drug delivery/imaging multifunctionality of mesoporous silica-based composite nanostructures.
Chen Y; Chen H; Shi J
Expert Opin Drug Deliv; 2014 Jun; 11(6):917-30. PubMed ID: 24746014
[TBL] [Abstract][Full Text] [Related]
9. Targeted Delivery of Sunitinib by MUC-1 Aptamer-Capped Magnetic Mesoporous Silica Nanoparticles.
Torabi M; Aghanejad A; Savadi P; Barzegari A; Omidi Y; Barar J
Molecules; 2023 Jan; 28(1):. PubMed ID: 36615606
[TBL] [Abstract][Full Text] [Related]
10. Targeted delivery of doxorubicin by magnetic mesoporous silica nanoparticles armed with mucin-1 aptamer.
Siminzar P; Omidi Y; Golchin A; Aghanejad A; Barar J
J Drug Target; 2020 Jan; 28(1):92-101. PubMed ID: 31062625
[TBL] [Abstract][Full Text] [Related]
11. Fabrication of mesoporous silica nanoparticles for targeted delivery of sunitinib to ovarian cancer cells.
Torabi M; Aghanejad A; Savadi P; Barzegari A; Omidi Y; Barar J
Bioimpacts; 2023; 13(3):255-267. PubMed ID: 37431477
[TBL] [Abstract][Full Text] [Related]
12. Aptamer Tethered Bio-Responsive Mesoporous Silica Nanoparticles for Efficient Targeted Delivery of Paclitaxel to Treat Ovarian Cancer Cells.
Salve R; Kumar P; Chaudhari BP; Gajbhiye V
J Pharm Sci; 2023 May; 112(5):1450-1459. PubMed ID: 36669561
[TBL] [Abstract][Full Text] [Related]
13. Mucin-1 aptamer-armed superparamagnetic iron oxide nanoparticles for targeted delivery of doxorubicin to breast cancer cells.
Aghanejad A; Babamiri H; Adibkia K; Barar J; Omidi Y
Bioimpacts; 2018; 8(2):117-127. PubMed ID: 29977833
[No Abstract] [Full Text] [Related]
14. Citric acid functionalized silane coupling versus post-grafting strategy for dual pH and saline responsive delivery of cisplatin by Fe
Abedi M; Abolmaali SS; Abedanzadeh M; Borandeh S; Samani SM; Tamaddon AM
Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109922. PubMed ID: 31499936
[TBL] [Abstract][Full Text] [Related]
15. Production of high loading insulin nanoparticles suitable for oral delivery by spray drying and freeze drying techniques.
Guo Y; Baldelli A; Singh A; Fathordoobady F; Kitts D; Pratap-Singh A
Sci Rep; 2022 Jun; 12(1):9949. PubMed ID: 35705561
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
